Neutralization of SARS-CoV-2 Omicron after vaccination of patients with myelodysplastic syndromes or acute myeloid leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Neutralization of SARS-CoV-2 Omicron after vaccination of patients with myelodysplastic syndromes or acute myeloid leukemia

Published:2022-05-05 Issue:18 Volume:139 Page:2842-2846
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Bellusci Lorenza¹^ORCID,Grubbs Gabrielle¹,Srivastava Pragya²,Nemeth Michael J.³,Griffiths Elizabeth A.²⁴^ORCID,Golding Hana¹,Khurana Surender¹^ORCID

Affiliation:

1. Division of Viral Products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, Silver Spring, MD; and

2. Department of Medicine,

3. Department of Immunology, and

4. Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

https://ashpublications.org/blood/article-pdf/139/18/2842/1895384/bloodbld2022016087.pdf

Reference16 articles.

1. Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell-directed therapies;Ghione;Blood.,2021

2. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients;Vijenthira;Blood.,2020

3. Cause of death in patients with lower-risk myelodysplastic syndrome;Dayyani;Cancer.,2010

4. Combination of frailty status and comorbidity score improves the stratification of survival in patients with myelodysplastic syndrome owing to good predictive capability for infection-related mortality;Sakatoku;Clin Lymphoma Myeloma Leuk.,2019

5. Incidence, etiology and timing of infections following azacitidine therapy for myelodysplastic syndromes;Trubiano;Leuk Lymphoma.,2017

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Severe COVID-19 in Vaccinated Adults With Hematologic Cancers in the Veterans Health Administration;JAMA Network Open;2024-02-23

2. COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches;Cell Communication and Signaling;2024-02-15

3. Multi-omics analysis of mucosal and systemic immunity to SARS-CoV-2 after birth;Cell;2023-10

4. Vaccine schedule recommendations and updates for patients with hematologic malignancy post‐hematopoietic cell transplant or CAR T‐cell therapy;Transplant Infectious Disease;2023-07-29

5. Booster effect of a third mRNA‐based COVID‐19 vaccine dose in patients with myeloid malignancies;Cancer Medicine;2023-07-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3